Prochlorperazine Maleate

CAS No. 84-02-6

Prochlorperazine Maleate( Meterazin (maleate) )

Catalog No. M16120 CAS No. 84-02-6

A phenothiazine antipsychotic used principally in the treatment of nausea; vomiting; and vertigo.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
25MG 34 In Stock
50MG 45 In Stock
100MG 59 In Stock
200MG 106 In Stock
500MG 200 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Prochlorperazine Maleate
  • Note
    Research use only, not for human use.
  • Brief Description
    A phenothiazine antipsychotic used principally in the treatment of nausea; vomiting; and vertigo.
  • Description
    A phenothiazine antipsychotic used principally in the treatment of NAUSEA; VOMITING; and VERTIGO. It is more likely than chlorpromazine to cause extrapyramidal disorders.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Meterazin (maleate)
  • Pathway
    GPCR/G Protein
  • Target
    Dopamine Receptor
  • Recptor
    D2
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    84-02-6
  • Formula Weight
    606.09
  • Molecular Formula
    C28H32ClN3O8S
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 15 mg/L (at 24 °C)
  • SMILES
    CN1CCN(CC1)CCCN2C3=C(SC4=CC=CC=C24)C=CC(=C3)Cl.C(=C\C(=O)O)\C(=O)O.C(=C\C(=O)O)\C(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hamik A, Peroutka SJ. Y ChemOthers Pharmacol. 1989;24(5):307-10.
molnova catalog
related products
  • Miriplatin

    Miriplatin (SM-11355) is a platinum complex used in TACE that has promise for the therapy of hepatocellular carcinoma (HCC).

  • CP-226269

    CP-226269 is a potent dopamine D4 receptor agonist that regulates calcium flux and has an EC50 value of 32.0 nM. CP 226269 can be used to study neurological disorders such as schizophrenia.

  • OS-3-106

    OS-3-106 ?is a novel arylamide phenylpiperazines, as partial agonists at the D3R in the adenylyl cyclase inhibition assay.